United States: Federal Circuit Decision Clarifies Application Of On-Sale Bar To Third-Party Manufacturers And Suppliers

On July 11, 2016, in The Medicines Company v. Hospira, Inc., the Federal Circuit issued a rare unanimous en banc opinion addressing the circumstances under which a patentee's manufacturing and supply agreements with a third-party contractor could trigger the on-sale bar under 35 U.S.C. § 102(b). The court's analysis focused exclusively on the first prong of the U.S. Supreme Court's on-sale bar test: "whether the [claimed] invention was the subject of a commercial sale or offer for sale" before the critical date of the patent claim. In an opinion written by Judge O'Malley, the court explained that activating the on-sale bar requires that "a product must be the subject of a commercial sale or offer for sale, and that a commercial sale is one that bears the general hallmarks of a sale pursuant to Section 2-106 of the Uniform Commercial Code." The court then set forth two guidelines for evaluating whether there exists a commercial sale or offer for sale: (i) "a contract manufacturer's sale to the inventor of manufacturing services" does not constitute "an invalidating sale under § 102(b)" of a claimed product when "neither title to the [product] nor the right to market the [product] passes to" the manufacturer; and (ii) "'stockpiling' by the purchaser of manufacturing services is not improper commercialization under § 102(b)" absent actual "commercial marketing."

The court's en banc decision focused upon the following facts: The patentee MedCo is a pharmaceutical company that does not have in-house manufacturing capabilities for producing drug batches. MedCo therefore contracted with a third-party manufacturer, Ben Venue Laboratories, to make drug batches. The challenged patent claims are directed to the drug product bivalirudin. Before the critical date of the patent claims, MedCo paid Ben Venue more than $300,000 "to manufacture three batches of the drug bivalirudin according to the patents-at-issue." The three drug batches "had a market value of well over $20 million." MedCo did not release the three batches for sale until after the critical date of the challenged claims, and MedCo did not transfer title of the drug batches to Ben Venue.

Against this background, the court reached two important holdings. First, the court determined that "sale of manufacturing services by a contract manufacturer to an inventor to create embodiments of the patented product for the inventor does not constitute a 'commercial sale' of the invention." Starting from the statutory language of Section 102(b), the court explained that the on-sale bar "requires that 'the invention' be 'on sale,'" and noted that the challenged claims covered drug products. The court then rejected the argument that "by manufacturing embodiments of the patented product for MedCo, Ben Venue put the invention 'on sale.'" Emphasizing the difference between product and process claims for purposes of Section 102(b), the court then stated that its precedent "never espoused the notion that, where the patent is to a product, the performance of the unclaimed process of creating the product, without any accompanying 'commercial sale' of the product itself, triggers the on-sale bar." The court placed prominent weight on the fact that "only manufacturing services were sold to the inventor—the invention was not."

The court also explained that the "absence of title transfer further underscores that the sale was only of Ben Venue's manufacturing services. Because Ben Venue lacked title, it was not free to use or sell the claimed products to anyone other than MedCo." Thus, according to the court, there was no cognizable sale under the Uniform Commercial Code ("UCC"), which "describes a 'sale' as 'the passing of title from the seller to the buyer for a price.'" While recognizing that UCC standards "do[] not have 'talismanic significance,'" the court nonetheless stressed "the usefulness of the UCC in analyzing the on-sale bar."

Second, the court held that "'stockpiling' by the purchaser of manufacturing services is not improper commercialization under § 102(b)." Observing that a fundamental objective of the on-sale bar is "preventing inventors from filing for patents a year or more after the invention has been commercially marketed, whether marketed by the inventor himself or a third party," the court made clear that "commercial benefit generally is not what triggers [the on-sale bar]; there must be a commercial sale or offer for sale." As the court put it, "commercial benefit—even to both parties in a transaction—is not enough ... the transaction must be one in which the product is 'on sale' in the sense that it is 'commercially marketed."' Applying these principles, the court explained that "[s]tockpiling—or building inventory—is, when not accompanied by an actual sale or offer for sale, mere pre-commercial activity in preparation for future sales." The court concluded that the "on sale bar is triggered by actual commercial marketing of the invention, not preparation for potential or eventual marketing." Accordingly, "stockpiling by an inventor with assistance of a contract manufacturer is no more improper than is stockpiling by an inventor in-house."

Recognizing that its prior decisions "expressly held that there is no 'supplier exception' to the on-sale bar," the court distinguished those cases as not involving the "facts and arguments considered" in the case before it. After cataloging the different factual circumstances presented in prior decisions, the court made clear that "to the extent language in those cases might be viewed as dictating a different result here, they are overruled with one important caveat: We still do not recognize a blanket 'supplier exception' to the what would otherwise constitute a commercial sale as we have characterized it today." Rather, the "focus must be on the commercial character of the transaction, not solely on the identity of the participants." The court then provided additional guidance, explaining that "[w]here the supplier has title to the patented product or process, the supplier receives blanket authority to market the product or disclose the process for manufacturing the product to others, or the transaction is a sale of product at full market value, even a transfer of product to the inventor may constitute a commercial sale under § 102(b)."

The Federal Circuit's decision provides increased predictability regarding the scope of the on-sale bar to pharmaceutical, electrical, and other industries where a patented invention is often manufactured or supplied by a third party, especially in the early stages of development and testing. Additionally, the court's opinion identifies key considerations that patentees must consider and address in drafting their manufacturing and supply agreements with third parties.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions